# Archimed acquires and merges Symbio and ProInnovera

Global private equity healthcare specialist Archimed acquired and simultaneously merged US-based Symbio and Germany-based ProInnovera in an all-equity deal.

- Type: Acquisition
- Announced: 2023-11-17
- Status: completed
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (acquirer)
- [Symbio](https://endata.com/companies/37933.md) (target)
- [ProInnovera](https://endata.com/companies/73870.md) (target)

## Sources

- [achelous.com](https://achelous.com/achelous-partners-advises-symbio-and-proinnovera-on-their-respective-sales-to-archimed/), 2023-11-17: "Global Private Equity healthcare specialist ARCHIMED has acquired and simultaneously merged US-based Symbio, and Germany-based Proinnovera in all-equity deal."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.